<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Card Anaesth</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Card Anaesth</journal-id>
      <journal-id journal-id-type="publisher-id">ACA</journal-id>
      <journal-title-group>
        <journal-title>Annals of Cardiac Anaesthesia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0971-9784</issn>
      <issn pub-type="epub">0974-5181</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27052086</article-id>
      <article-id pub-id-type="pmc">4900359</article-id>
      <article-id pub-id-type="publisher-id">ACA-19-357</article-id>
      <article-id pub-id-type="doi">10.4103/0971-9784.179620</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Heart to Heart Blog: Interesting Images</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Rare postoperative delayed malignant hyperthermia after off-pump coronary bypass surgery and brief review of literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Raut</surname>
            <given-names>Monish S.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kar</surname>
            <given-names>Sibashankar</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maheshwari</surname>
            <given-names>Arun</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shivnani</surname>
            <given-names>Ganesh</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>Arun</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Daniel</surname>
            <given-names>Elvin</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Joshi</surname>
            <given-names>Sandeep</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Motihar</surname>
            <given-names>Amit</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>Priyanka</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">2</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of Cardiac Anaesthesiology, Sir Ganga Ram Hospital, New Delhi, India</aff>
      <aff id="aff2"><label>1</label>Department of Cardiac Surgery, Sir Ganga Ram Hospital, New Delhi, India</aff>
      <aff id="aff3"><label>2</label>Department of Cardiac Anaesthesiology, Amrita Institute of Medical Sciences, Kochi, Kerala, India</aff>
      <author-notes>
        <corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Monish S. Raut, Department of Cardiac Anaesthesiology, Sir Ganga Ram Hospital, New Delhi, India. E-mail: <email xlink:href="drmonishraut@gmail.com">drmonishraut@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Apr-Jun</season>
        <year>2016</year>
      </pub-date>
      <volume>19</volume>
      <issue>2</issue>
      <fpage>357</fpage>
      <lpage>362</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>2</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; 2016 Annals of Cardiac Anaesthesia</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Postoperative malignant hyperthermia (MH) is a very rare phenomena. It is generally observed within less than an hour after discontinuation of the anesthetic trigger. Present case describes rare delayed postoperative presentation of MH after off-pump coronary bypass surgery. Prompt recognition and immediate treatment with dantrolene can effectively treat the fatal syndrome. Family education and genetic counseling should be encouraged.</p>
      </abstract>
      <kwd-group>
        <kwd>Hyperthermia</kwd>
        <kwd>Malignant hyperthermia</kwd>
        <kwd>Rigidity</kwd>
        <kwd>Triggering anesthetic agents</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec1-1">
      <title>INTRODUCTION</title>
      <p>Malignant hyperthermia (MH) is pharmacogenetic syndrome inherited in an autosomal dominant way. Mutations in genes coding for calcium channel proteins (RYR1) and receptors (dihydropyridine) are responsible for MH susceptibility in 30&#x2013;50% of the cases.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] The incidence of MH episodes in the general population is estimated as 1:100,000 administered anesthetics.[<xref rid="ref3" ref-type="bibr">3</xref>] This may be an underestimated prevalence as unrecognized, mild, or atypical reactions occur due to variable penetrance of the inherited trait.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>] The occurrence of MH has been reported in all ethnic groups in all parts of the world. About 45&#x2013;52% of reported events has been seen in children below 19 years of age.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref6" ref-type="bibr">6</xref>]</p>
    </sec>
    <sec id="sec1-2">
      <title>CASE REPORT</title>
      <p>Sixty-eight-year-old gentleman presented with retrosternal chest discomfort since 10 days. He was evaluated thoroughly at our center and found to have severe triple vessel coronary artery disease. He was scheduled for coronary artery bypass grafting (CABG) surgery. Preoperative history was not suggestive of any use of antipsychotic medications nor any medical illness or any previous anesthesia exposure. There was no history suggestive of any muscle disorders in his family. Anesthesia induction was done with intravenous (IV) injection fentanyl 2 mcg/kg, midazolam 0.03 mg/kg, and propofol 2 mg/kg with inhalation agent sevoflurane. The patient was intubated by using IV injection of rocuronium 1 mg/kg. Anesthesia was maintained by inhalational agent isoflurane 2&#x2013;3% keeping bispectral index 40&#x2013;60. Intraoperatively, dexmedetomidine infusion 0.5 mcg/kg/h along with intermittent fentanyl doses were used for analgesia. Muscle relaxant vecuronium was used intermittently. Off-pump CABG was done successfully. Total surgical duration was 3.5 h. Patient's temperature remained between 35&#xB0;C and 36&#xB0;C intraoperatively. End-tidal carbon dioxide (ETCO<sub>2</sub>) was between 30 and 35 mm Hg with mechanical ventilation at tidal volume 10 ml/kg and respiratory rate of 12/min. Intraoperatively, metabolic or respiratory acidosis or electrolytes imbalance was not noticed with lactate level of 0.5 mmol/L. After the skin closure, isoflurane inhalation was stopped and propofol infusion 150 mcg/kg/min was started for sedation before shifting the patient to the cardiac recovery room. Patient's ETCO<sub>2</sub> started rising from 35 to 65 mmHg with the same ventilatory setting 60 min after the completion of surgery. Temperature showed rising trend from 36&#xB0;C to 38.8&#xB0;C. Generalized muscle rigidity was observed including masseter muscle spasm despite using vecuronium. Arterial blood gas analysis revealed mixed respiratory and metabolic acidosis with raised lactate level of 5 mmol/L (pH 7.20, PaCO<sub>2</sub> 62 mmHg, and base excess &#x2013; 9 mEq/L). Heart rate was 110/min and mean arterial blood pressure of 70 mmHg was maintained with an infusion of noradrenaline 0.5 mcg/kg/min. Electrocardiogram showed sinus tachycardia with intermittent appearance of premature ventricular contractions. Serum potassium increased from 3.8 to 4.9 mEq/L. Any fault in ventilator machine and breathing circuit were checked and ruled out. Ventilator settings were adjusted to normalize ETCO<sub>2</sub>. Cooling blanket and cold saline were used to decrease the core body temperature. IV frusemide 1 mg/kg was injected to augment urine output to decrease the probability of acute tubular necrosis induced by suspected myoglobinuria. Considering clinical suspicion of MH, IV dantrolene 1 mg/kg was administered within 30 min of noticing the symptoms. Patient's limb rigidity decreased to some extent and temperature dropped to 38.2&#xB0;C. Oral dantrolene 50 mg qid was started due to nonavailability of IV dantrolene. Patient's creatinine phosphokinase (CPK) enzyme level was raised. The patient was mechanically ventilated for another 2 days. Patient was extubated on the 3<sup>rd</sup> postoperative day, as the muscle rigidity reduced significantly and temperature normalized with good hemodynamic stability without any inotropic support. Oral dantrolene was stopped after the 3<sup>rd</sup> day. CPK enzyme showed decreasing trend [<xref ref-type="fig" rid="F1">Figure 1</xref>]. Postoperative course after the event was stable and smooth. Patient and his family members were counseled about the event occurred and advised about genetic testing for MH. Patient was given anesthesia summary at the time of discharge stating MH occurrence and its management.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Course of the events</p>
        </caption>
        <graphic xlink:href="ACA-19-357-g001"/>
      </fig>
      <p>Closest differential diagnosis with features of muscle rigidity and hyperthermia is a neuroleptic malignant syndrome, which was ruled out in the present case due to the absence of history of antipsychotic medications. Our patient had a rise in CPK more than 5000 IU/L. Normal increase in CPK after cardiac or great vessel surgeries can be up to 1100 IU/L.[<xref rid="ref7" ref-type="bibr">7</xref>] As per the clinical grading scale (CGS), clinical features of the present case scored 58 which suggests it was an almost certain case of MH [<xref ref-type="fig" rid="F2">Figure 2</xref>]. MH in the present case is diagnosis by exclusion, and it was reaffirmed by the disappearance of symptoms after dantrolene therapy. We could not perform muscle biopsy to confirm the diagnosis. Liver function tests were monitored and found to be normal during dantrolene therapy.</p>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Malignant hyperthermia clinical grading scale</p>
        </caption>
        <graphic xlink:href="ACA-19-357-g002"/>
      </fig>
      <p>In the present case, features of MH appeared 1 h postoperatively. The case was managed successfully using IV dantrolene initially followed by the oral form of dantrolene.</p>
    </sec>
    <sec sec-type="discussion" id="sec1-3">
      <title>DISCUSSION</title>
      <p>MH susceptible (MHS), patient when exposed to triggering anesthetic agents, causes uncontrolled intracellular release of calcium in skeletal muscle with resultant sustained muscle contraction. Such muscular hypermetabolic state produces rigidity, hyperthermia, and acidosis [<xref ref-type="fig" rid="F3">Figure 3</xref>].</p>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Pathophysiology of malignant hyperthermia</p>
        </caption>
        <graphic xlink:href="ACA-19-357-g003"/>
      </fig>
      <p>Intraoperative clinical diagnosis of MH may be difficult due to the nonspecific nature of MH clinical signs and symptoms. Larach <italic>et al</italic>. devised the CGS as a set of clinical diagnostic criteria for MH.[<xref rid="ref8" ref-type="bibr">8</xref>] As per the scale, clinical features of the present case scored 53 which suggests it was an almost certain case of MH. Cases developing MH during cardiopulmonary bypass (CPB) in cardiac surgery have been reported.[<xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref>] However, classical features of MH are obscured and disguised by the hypothermic CPB.[<xref rid="ref11" ref-type="bibr">11</xref>]</p>
      <p>Postoperative MH is very rare (&lt;2% of all cases) and generally observed within less than an hour after discontinuation of the anesthetic trigger.[<xref rid="ref12" ref-type="bibr">12</xref>] After reviewing published cases of MH, North American Malignant Hyperthermia Registry (NAMHR) found postoperative MH is a rare event which happened in 10 of 528 suspected MH cases (1.9%) reported to the NAMHR. None of these cases had hyperthermia as an initial presenting sign.[<xref rid="ref12" ref-type="bibr">12</xref>] NAMHR suggested that initial postoperative fever without signs of hypermetabolism is unlikely to be MH. Postoperative MH cases presenting more than 1 h after discontinuation of anesthesia should warrant investigation of alternative diagnoses.[<xref rid="ref12" ref-type="bibr">12</xref>] Firstenberg <italic>et al</italic>. reported a successfully treated case of delayed MH after 4.5 h of isoflurane inhalational anesthesia in a case of on-pump CABG.[<xref rid="ref13" ref-type="bibr">13</xref>] MH cases have presented in a delayed or atypical manner with a latency of 0&#x2013;40 min in the postoperative period.[<xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref14" ref-type="bibr">14</xref>]</p>
      <p>Considering rapidly, progressive, and fulminant course of MH, it is essential for the anesthesiologist to diagnose the condition as early as possible to minimize mortality and MH-related complications. Visoiu <italic>et al</italic>. have reported shorter MH onset time in the presence of halothane and after succinylcholine in all anesthetics. MH onset time was shorter during sevoflurane anesthesia than during isoflurane or desflurane in the human cohort of MH cases.[<xref rid="ref15" ref-type="bibr">15</xref>] Larach <italic>et al</italic>. observed cardiac dysfunction and level of consciousness change as the most common MH-related complications.[<xref rid="ref16" ref-type="bibr">16</xref>] More the time period between the first clinical sign and dantrolene administration, higher complication rate was observed. Other studies also suggested early dantrolene use can reduce the MH-related complications.[<xref rid="ref16" ref-type="bibr">16</xref><xref rid="ref17" ref-type="bibr">17</xref>] Riazi <italic>et al</italic>. reported more than 50 min delay in the administration of dantrolene raised complication rate to 100%. The most common complication in this study was renal dysfunction (14.7%).[<xref rid="ref18" ref-type="bibr">18</xref>] In the present case, we managed to administer dantrolene in 30 min after diagnosing the symptoms.</p>
      <p>Dantrolene is recommended in the dose of 2.5 mg/kg every 5 min until a clinical improvement is seen.[<xref rid="ref19" ref-type="bibr">19</xref><xref rid="ref20" ref-type="bibr">20</xref>] Previous studies suggested that no dosing adjustments need to be made during CPB, as there is only a slight decrease in blood levels due to dilution.[<xref rid="ref20" ref-type="bibr">20</xref>] Improvement in symptoms is generally observed within 30&#x2013;60 min. No clinical improvement even after administration of 10 mg/kg warrants a review of differential diagnosis.[<xref rid="ref19" ref-type="bibr">19</xref><xref rid="ref20" ref-type="bibr">20</xref>] Recrudescence of symptoms is observed in up to 25% of patients after successful treatment at a mean of 13 h (standard deviation, 13 h) after the initial reaction[<xref rid="ref21" ref-type="bibr">21</xref>] and commonly in patients with increased muscle mass.[<xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref22" ref-type="bibr">22</xref>] Hence, it is suggested to continue dantrolene in maintenance doses (1 mg/kg IV every 4&#x2013;6 h) for 24&#x2013;48 h after the last noticed sign of acute MH.[<xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref23" ref-type="bibr">23</xref>]</p>
      <p>Dantrolene can cause a profound muscular weakness by interfering with the intracellular calcium handling.[<xref rid="ref23" ref-type="bibr">23</xref><xref rid="ref24" ref-type="bibr">24</xref>] Higher than recommended doses has been reported to have negative inotropic effects in animal studies.[<xref rid="ref25" ref-type="bibr">25</xref><xref rid="ref26" ref-type="bibr">26</xref>] Dantrolene can also cause fatal and nonfatal hepatic failure after long-term use.[<xref rid="ref27" ref-type="bibr">27</xref><xref rid="ref28" ref-type="bibr">28</xref>] Shih <italic>et al</italic>. described that intraoperative administration of low-dose dantrolene, 1.2 mg/kg, was effective in treating hyperthermia, hypercapnia, and hyperkalemia.[<xref rid="ref29" ref-type="bibr">29</xref>] In the present case, we also used IV dantrolene in the low dose of 1 mg/kg successfully and oral dantrolene for 48 h to prevent the recurrence.</p>
      <p>Use of oral dantrolene in MH has been reported anecdotally.[<xref rid="ref30" ref-type="bibr">30</xref><xref rid="ref31" ref-type="bibr">31</xref><xref rid="ref32" ref-type="bibr">32</xref>] Oral dantrolene sodium is well absorbed and achieves peak blood levels 3&#x2013;6 h after ingestion.[<xref rid="ref33" ref-type="bibr">33</xref>] Oral dantrolene 5 mg/kg (divided 3&#x2013;4 times a day) can attain acceptable plasma level of the drug.[<xref rid="ref31" ref-type="bibr">31</xref>]</p>
      <p>Dantrolene was stopped in our case when the following criteria were met: Core temp is &lt;38&#xB0;C, metabolic stability for 24 h, muscle is no longer rigid, creatine kinase is decreasing, and no evidence of myoglobinuria.</p>
      <p>Complications such as hypercarbia, hyperthermia, electrolyte abnormalities, and arrhythmias should be managed with conventional measures, like mechanical ventilation, systemic cooling, and anti-arrhythmic drugs.[<xref rid="ref13" ref-type="bibr">13</xref>] Cardiac surgical patients are generally prone to develop an acute renal injury. Rhabdomyolysis in untreated MH can cause myoglobin-induced kidney damage.[<xref rid="ref6" ref-type="bibr">6</xref>] Aggressive fluid replacement with crystalloids and adequate diuresis can decrease the risk of myoglobin precipitation in renal tubules.[<xref rid="ref34" ref-type="bibr">34</xref>] Excessive physical activity in a hot, humid environment can trigger MHS human beings.[<xref rid="ref35" ref-type="bibr">35</xref>] Patients with a preexisting fever are more prone to develop an episode of MH.[<xref rid="ref34" ref-type="bibr">34</xref>] Role of heat in triggering MH in human beings is not known, however a modulating effect on a developing crisis must be presumed.[<xref rid="ref7" ref-type="bibr">7</xref>] Rapid and exaggerated rewarming during CPB can be a potential risk factor. Slow rewarming till 36&#xB0;C is advisable. Core temperature should be maintained &lt;36&#xB0;C during the postoperative period in MHS patients.[<xref rid="ref34" ref-type="bibr">34</xref>] Gasoline vapors and serotonin receptor agonists are also said to be potential trigger agents.[<xref rid="ref36" ref-type="bibr">36</xref><xref rid="ref37" ref-type="bibr">37</xref>] Usefulness of CPB has been reported in noncardiac surgery patients who had MH episode during general anesthesia. The advantages of CPB in MH patients include ultrafiltration, temperature control, normalization of electrolytes, control of acidosis, cytokine removal, and supporting the circulation of the patient.[<xref rid="ref38" ref-type="bibr">38</xref>] Witherspoon have reported the use of extracorporeal membrane oxygenation for cardiac failure due to hypermetabolic episode possibly caused by MH.[<xref rid="ref39" ref-type="bibr">39</xref>]</p>
      <p>Anesthesia can be safely given to MHS patients with nontriggering agents. Close monitoring of minute ventilation, ETCO<sub>2</sub> levels, and core body temperature should be done in MHS patients. MH triggering agents are inhalational halogenated anesthetics (e.g., sevoflurane, desflurane, isoflurane, enflurane, and halothane) and depolarizing muscle relaxant like succinylcholine. Safe agents that can be safely administered to MHS patients include - all IV sedatives and anesthetic including propofol, dexmedetomidine, ketamine, etomidate, and barbiturates. All local anesthetics (e.g., ropivacaine, lidocaine, and bupivacaine), nondepolarizing neuromuscular blockers (e.g., atracurium, vecuronium, and rocuronium), analgesics and anxiolytics (opioids and benzodiazepines), and inhalational agents limited to nitrous oxide and xenon are safe. Perioperative dantrolene for prophylaxis is not recommended by the Malignant Hyperthermia Association of the United States.[<xref rid="ref40" ref-type="bibr">40</xref>]</p>
      <p>After recovery from MH episode, all details should be noted in anesthesia discharge summary and patient and family should be counseled specifically about the following points - avoid anesthesia with triggering agents, avoid exercise in excessive heat which can be a triggering event. Inform family members of the possible MH reaction, as MHS is a genetic condition.</p>
      <p>Recognizing these genetically-susceptible individuals is the mainstay of prevention.</p>
      <p>Avoiding anesthetic triggers and prompt use of dantrolene during acute event occurs have decreased the mortality due to MH from historic rates of 70% to about 5%.[<xref rid="ref41" ref-type="bibr">41</xref><xref rid="ref42" ref-type="bibr">42</xref>] The present case describe a rare delayed postoperative presentation of MH after off-pump coronary bypass surgery. Prompt recognition and immediate treatment with low dose IV dantrolene followed by oral form can effectively reverse potentially fatal syndrome. Family education and genetic counseling should be encouraged.</p>
      <sec id="sec2-1">
        <title>Financial support and sponsorship</title>
        <p>Nil.</p>
      </sec>
      <sec id="sec2-2">
        <title>Conflicts of interest</title>
        <p>There are no conflicts of interest.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davis</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Brandom</surname>
              <given-names>BW</given-names>
            </name>
          </person-group>
          <article-title>The association of malignant hyperthermia and unusual disease: When you&#x2019;re hot you&#x2019;re hot or maybe not</article-title>
          <source>Anesth Analg</source>
          <year>2009</year>
          <volume>109</volume>
          <fpage>1001</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">19762721</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carpenter</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Quinnell</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Ringrose</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hogg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Casson</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genetic variation in RYR1 and malignant hyperthermia phenotypes</article-title>
          <source>Br J Anaesth</source>
          <year>2009</year>
          <volume>103</volume>
          <fpage>538</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="pmid">19648156</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brady</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001-2005</article-title>
          <source>Anesth Analg</source>
          <year>2009</year>
          <volume>109</volume>
          <fpage>1162</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">19762744</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Larach</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Gronert</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Brandom</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Lehman</surname>
              <given-names>EB</given-names>
            </name>
          </person-group>
          <article-title>Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006</article-title>
          <source>Anesth Analg</source>
          <year>2010</year>
          <volume>110</volume>
          <fpage>498</fpage>
          <pub-id pub-id-type="pmid">20081135</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bendixen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Skovgaard</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>Ording</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Analysis of anaesthesia in patients suspected to be susceptible to malignant hyperthermia before diagnostic <italic>in vitro</italic> contracture test</article-title>
          <source>Acta Anaesthesiol Scand</source>
          <year>1997</year>
          <volume>41</volume>
          <fpage>480</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">9150775</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenberg</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pollock</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Stowell</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Malignant hyperthermia</article-title>
          <source>Orphanet J Rare Dis</source>
          <year>2007</year>
          <volume>2</volume>
          <fpage>21</fpage>
          <pub-id pub-id-type="pmid">17456235</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yousef</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Vaida</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Somri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mogilner</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lanir</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tamir</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Changes in creatine phosphokinase (CK) concentrations after minor and major surgeries in children</article-title>
          <source>Br J Anaesth</source>
          <year>2006</year>
          <volume>96</volume>
          <fpage>786</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">16595613</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Larach</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Localio</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Denborough</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Ellis</surname>
              <given-names>FR</given-names>
            </name>
            <name>
              <surname>Gronert</surname>
              <given-names>GA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A clinical grading scale to predict malignant hyperthermia susceptibility</article-title>
          <source>Anesthesiology</source>
          <year>1994</year>
          <volume>80</volume>
          <fpage>771</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">8024130</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pandya</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>O&#x2019;Leary</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>Development of malignant hyperthermia post-cardiopulmonary bypass during surgery for mitral valve replacement</article-title>
          <source>J Cardiothorac Vasc Anesth</source>
          <year>2003</year>
          <volume>17</volume>
          <fpage>625</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">14579218</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franklin</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Lorinc</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Donahue</surname>
              <given-names>BS</given-names>
            </name>
          </person-group>
          <article-title>Malignant hyperthermia-like manifestations in a two-month-old child with Holt-Oram syndrome undergoing cardiac surgery</article-title>
          <source>J Cardiothorac Vasc Anesth</source>
          <year>2014</year>
          <volume>28</volume>
          <fpage>1326</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">24011877</pub-id>
        </element-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>MacGillivray</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Jann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Vanker</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gemmell</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mahomedy</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
          <article-title>Development of malignant hyperthermia obscured by cardiopulmonary bypass</article-title>
          <source>Can Anaesth Soc J</source>
          <year>1986</year>
          <volume>33</volume>
          <fpage>509</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">3742327</pub-id>
        </element-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Litman</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Flood</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YL</given-names>
            </name>
            <name>
              <surname>Tobin</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Postoperative malignant hyperthermia: An analysis of cases from the North American Malignant Hyperthermia Registry</article-title>
          <source>Anesthesiology</source>
          <year>2008</year>
          <volume>109</volume>
          <fpage>825</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">18946294</pub-id>
        </element-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Firstenberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Abel</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Blais</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Andritsos</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Delayed malignant hyperthermia after routine coronary artery bypass</article-title>
          <source>Ann Thorac Surg</source>
          <year>2010</year>
          <volume>89</volume>
          <fpage>947</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">20172160</pub-id>
        </element-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Papadimos</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Almasri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Padgett</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Rush</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>A suspected case of delayed onset malignant hyperthermia with desflurane anesthesia</article-title>
          <source>Anesth Analg</source>
          <year>2004</year>
          <volume>98</volume>
          <fpage>548</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">14742405</pub-id>
        </element-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Visoiu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Wieland</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Brandom</surname>
              <given-names>BW</given-names>
            </name>
          </person-group>
          <article-title>Anesthetic drugs and onset of malignant hyperthermia</article-title>
          <source>Anesth Analg</source>
          <year>2014</year>
          <volume>118</volume>
          <fpage>388</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="pmid">24445637</pub-id>
        </element-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Larach</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Gronert</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Brandom</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Lehman</surname>
              <given-names>EB</given-names>
            </name>
          </person-group>
          <article-title>Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006</article-title>
          <source>Anesth Analg</source>
          <year>2010</year>
          <volume>110</volume>
          <fpage>498</fpage>
          <lpage>507</lpage>
          <pub-id pub-id-type="pmid">20081135</pub-id>
        </element-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Migita</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mukaida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kawamoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yuge</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Fulminant-type malignant hyperthermia in Japan: Cumulative analysis of 383 cases</article-title>
          <source>J Anesth</source>
          <year>2007</year>
          <volume>21</volume>
          <fpage>285</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">17458663</pub-id>
        </element-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Riazi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Larach</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wijeysundera</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Massey</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kraeva</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Malignant hyperthermia in Canada: Characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands</article-title>
          <source>Anesth Analg</source>
          <year>2014</year>
          <volume>118</volume>
          <fpage>381</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">23842196</pub-id>
        </element-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steinfath</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wappler</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Scholz</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Malignant hyperthermia. General, clinical and experimental aspects</article-title>
          <source>Anaesthesist</source>
          <year>2002</year>
          <volume>51</volume>
          <fpage>328</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">12063729</pub-id>
        </element-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Comunale</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>DiNardo</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Pharmacokinetics of dantrolene in an adult patient undergoing cardiopulmonary bypass</article-title>
          <source>J Cardiothorac Vasc Anesth</source>
          <year>1991</year>
          <volume>5</volume>
          <fpage>153</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">1863728</pub-id>
        </element-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burkman</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Posner</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Domino</surname>
              <given-names>KB</given-names>
            </name>
          </person-group>
          <article-title>Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions</article-title>
          <source>Anesthesiology</source>
          <year>2007</year>
          <volume>106</volume>
          <fpage>901</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">17457120</pub-id>
        </element-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nelson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Litman</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Malignant hyperthermia in children: An analysis of the North American malignant hyperthermia registry</article-title>
          <source>Anesth Analg</source>
          <year>2014</year>
          <volume>118</volume>
          <fpage>369</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">24299931</pub-id>
        </element-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Podranski</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bouillon</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schumacher</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Taguchi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sessler</surname>
              <given-names>DI</given-names>
            </name>
            <name>
              <surname>Kurz</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Compartmental pharmacokinetics of dantrolene in adults: Do malignant hyperthermia association dosing guidelines work?</article-title>
          <source>Anesth Analg</source>
          <year>2005</year>
          <volume>101</volume>
          <fpage>1695</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">16301243</pub-id>
        </element-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wappler</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Malignant hyperthermia</article-title>
          <source>Eur J Anaesthesiol</source>
          <year>2001</year>
          <volume>18</volume>
          <fpage>632</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">11553240</pub-id>
        </element-citation>
      </ref>
      <ref id="ref25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saltzman</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Kates</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Corke</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Norfleet</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Heath</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <article-title>Hyperkalemia and cardiovascular collapse after verapamil and dantrolene administration in swine</article-title>
          <source>Anesth Analg</source>
          <year>1984</year>
          <volume>63</volume>
          <fpage>473</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">6711841</pub-id>
        </element-citation>
      </ref>
      <ref id="ref26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyler</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Wesseling</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Agoston</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>The effects of dantrolene sodium on cardiac and skeletal muscle in rats</article-title>
          <source>Eur J Pharmacol</source>
          <year>1976</year>
          <volume>39</volume>
          <fpage>127</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">964299</pub-id>
        </element-citation>
      </ref>
      <ref id="ref27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Dantrolene sodium and hepatic injury</article-title>
          <source>Neurology</source>
          <year>1990</year>
          <volume>40</volume>
          <fpage>1427</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="pmid">2392230</pub-id>
        </element-citation>
      </ref>
      <ref id="ref28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Utili</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Boitnott</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Zimmerman</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Dantrolene-associated hepatic injury. Incidence and character</article-title>
          <source>Gastroenterology</source>
          <year>1977</year>
          <volume>72</volume>
          <issue>4 Pt 1</issue>
          <fpage>610</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">838213</pub-id>
        </element-citation>
      </ref>
      <ref id="ref29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shih</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Pao</surname>
              <given-names>YY</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>CJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Low-dose dantrolene is effective in treating hyperthermia and hypercapnia, and seems not to affect recovery of the allograft after liver transplantation: Case report</article-title>
          <source>Transplant Proc</source>
          <year>2010</year>
          <volume>42</volume>
          <fpage>858</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">20430190</pub-id>
        </element-citation>
      </ref>
      <ref id="ref30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kang</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>A suspected case of malignant hyperthermia that was successfully treated with dantrolene administration via nasogastric tube</article-title>
          <source>Korean J Anesthesiol</source>
          <year>2012</year>
          <volume>63</volume>
          <fpage>378</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">23115697</pub-id>
        </element-citation>
      </ref>
      <ref id="ref31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allen</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Cattran</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Lalande</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Plasma levels of dantrolene following oral administration in malignant hyperthermia-susceptible patients</article-title>
          <source>Anesthesiology</source>
          <year>1988</year>
          <volume>69</volume>
          <fpage>900</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">3057938</pub-id>
        </element-citation>
      </ref>
      <ref id="ref32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nagase</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Naganuma</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ryo</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kawashima</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Treatment of malignant hyperthermia by dantrolene sodium administered through a nasogastric tube</article-title>
          <source>Masui</source>
          <year>1984</year>
          <volume>33</volume>
          <fpage>1021</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">6512969</pub-id>
        </element-citation>
      </ref>
      <ref id="ref33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krach</surname>
              <given-names>LE</given-names>
            </name>
          </person-group>
          <article-title>Pharmacotherapy of spasticity: Oral medications and intrathecal baclofen</article-title>
          <source>J Child Neurol</source>
          <year>2001</year>
          <volume>16</volume>
          <fpage>31</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">11225954</pub-id>
        </element-citation>
      </ref>
      <ref id="ref34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Metterlein</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zink</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Kranke</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Haneya</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Graf</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kranke</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Cardiopulmonary bypass in malignant hyperthermia susceptible patients: A systematic review of published cases</article-title>
          <source>J Thorac Cardiovasc Surg</source>
          <year>2011</year>
          <volume>141</volume>
          <fpage>1488</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="pmid">21376345</pub-id>
        </element-citation>
      </ref>
      <ref id="ref35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wappler</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fiege</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Steinfath</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Agarwal</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Scholz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis</article-title>
          <source>Anesthesiology</source>
          <year>2001</year>
          <volume>94</volume>
          <fpage>95</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="pmid">11135728</pub-id>
        </element-citation>
      </ref>
      <ref id="ref36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wappler</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Roewer</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>K&#xF6;chling</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Scholz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Steinfath</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rumberger</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effects of serotonin 2 receptor agonists on skeletal muscle preparations in patients with a disposition toward malignant hyperthermia</article-title>
          <source>Anaesthesist</source>
          <year>1995</year>
          <volume>44</volume>
          <fpage>538</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">7573901</pub-id>
        </element-citation>
      </ref>
      <ref id="ref37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anetseder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hartung</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Klepper</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Reichmann</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Gasoline vapors induce severe rhabdomyolysis</article-title>
          <source>Neurology</source>
          <year>1994</year>
          <volume>44</volume>
          <fpage>2393</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">7991133</pub-id>
        </element-citation>
      </ref>
      <ref id="ref38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edwards</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Siwek</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Successful use of cardiopulmonary bypass and ultrafiltration for metabolic resuscitation of a moribund child with acute perianesthetic rhabdomyolysis; a case report of unsuspected malignant hyperthermia</article-title>
          <source>J Extra Corpor Technol</source>
          <year>2000</year>
          <volume>32</volume>
          <fpage>103</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="ref39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Witherspoon</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>ECMO for resuscitation of an infant immediately post-op VSD closure and RVOT repair: A case report of possible malignant hyperthermia</article-title>
          <source>Prog Pediatr Cardiol</source>
          <year>2008</year>
          <volume>24</volume>
          <fpage>131</fpage>
          <lpage>5</lpage>
        </element-citation>
      </ref>
      <ref id="ref40">
        <label>40</label>
        <element-citation publication-type="webpage">
          <date-in-citation>Last accessed on 2015 Oct 18</date-in-citation>
          <comment>Available from: <uri xlink:type="simple" xlink:href="http://www.mhaus.org/healthcareprofessionals/be-prepared/post-operative-procedure">http://www.mhaus.org/healthcareprofessionals/be-prepared/post-operative-procedure</uri></comment>
        </element-citation>
      </ref>
      <ref id="ref41">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Larach</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Brandom</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Gronert</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Lehman</surname>
              <given-names>EB</given-names>
            </name>
          </person-group>
          <article-title>Cardiac arrests and deaths associated with malignant hyperthermia in North America from 1987 to 2006: A report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States</article-title>
          <source>Anesthesiology</source>
          <year>2008</year>
          <volume>108</volume>
          <fpage>603</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="pmid">18362591</pub-id>
        </element-citation>
      </ref>
      <ref id="ref42">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosero</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Adesanya</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Timaran</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Joshi</surname>
              <given-names>GP</given-names>
            </name>
          </person-group>
          <article-title>Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005</article-title>
          <source>Anesthesiology</source>
          <year>2009</year>
          <volume>110</volume>
          <fpage>89</fpage>
          <pub-id pub-id-type="pmid">19104175</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
